Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

NCT00574873

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • Tower Cancer Research Foundation (TCRF) Beverly Hills, California, United States
  • Robert A Moss, MD, FACP, Inc Fountain Valley, California, United States
  • UCSD Medical Center-Thornton La Jolla, California, United States
View all 165 locations
View Trial Details
Completed

Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

NCT01933906

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung Wels, Upper Austria, Austria
  • Universitätskliniken Innsbruck, Univ.-Klinik f.Innere Medizin V Hämtologie u. Onkologie Innsbruck, Austria
  • Ordensklinikum Linz - Elisabethinen Linz, Austria
  • Universitätsklinikum der PMU Salzburg, Universitätsklinik für Innere Medizin III Salzburg, Austria
View Trial Details

Related conditions